Sinovent

About:

Sinovent is engaged in the technical development, consulting, and services of biological medicines.

Website: https://www.evopointbio.com/en

Top Investors: Tencent, CDIB Capital, Tsinghua Holdings Capital, CCB International, Oceanpine Capital

Description:

Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.